FDA Inspection 1002295 — Nippon Sanso Matheson, Inc.
The FDA completed an inspection of Nippon Sanso Matheson, Inc. on Feb 10, 2017 in Albany, OR. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Feb 10, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Albany, OR (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 1134 | 21 CFR 211.25(b) | Supervisor Training/Education/Experience |
| 2011 | 21 CFR 211.188(a) | Accurate reproduction |
| 3565 | 21 CFR 211.58 | Buildings not maintained in good state of repair |